Legislation & Regulation

Discover essential legislative and regulatory resources tailored for managed care pharmacy professionals. Stay informed with the latest updates, policies, and advocacy tools to effectively navigate and influence the health care landscape.

Resource

AMCP Summary: 2019 Draft Call Letter

On February 1, 2018, CMS released its 2019 Draft Call Letter. AMCP prepared in initial summary of the highlights contained in the Draft Call Letter. Of particular interest to AMCP members, CMS proposed new strategies for identifying potential opioid abuse which will work with the proposed codification of the current Opioid Monitoring System (OMS) under the Comprehensive Addiction and Recovery Act of 2015 (CARA).
Medicare Part D, Legislation & Regulation
Resource

AMCP Delivers Remarks at FDA Opioid Policy Steering Committee Meeting on How the FDA Can Help Address the Opioid Epidemic

On January 30, 2018, AMCP delivered remarks to the FDA at an opioid policy steering committee meeting. AMCP commended the FDA for establishing the OPSC and for seeking public input to help identify key areas of focus that the FDA can address. AMCP focused on the following three areas; REMS; Labeling, Packaging, Storage, and Disposal; and Additional Focus Areas where AMCP feels that the FDA can be actively involved in combating the opioid epidemic.
Legislation & Regulation
Letters, Statements & Analysis

AMCP Sends Letter to Michigan House Health Policy Committee Citing Concerns with HB 4472 and Regulations on Pharmacists Substituting Interchangeable Biological Products

The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of House Bill 4472 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists.
Legislation & Regulation